Citigroup’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.3K | Sell |
|
|||||
|
2025
Q1 | $26.3K | Sell |
|
|||||
|
2024
Q4 | $71.5K | Sell |
|
|||||
|
2024
Q3 | $87.7K | Sell |
|
|||||
|
2024
Q2 | $141K | Buy |
|
|||||
|
2024
Q1 | $28.6K | Buy |
|
|||||
|
2023
Q4 | $14.2K | Buy |
|
|||||
|
2023
Q3 | $2.15K | Sell |
|
|||||
|
2023
Q2 | $68.5K | Sell |
|
|||||
|
2023
Q1 | $2.84M | Buy |
|
|||||
|
2022
Q4 | $1.73M | Sell |
|
|||||
|
2022
Q3 | $3.32M | Buy |
|
|||||
|
2022
Q2 | $2.12M | Buy |
|
|||||
|
2022
Q1 | $942K | Sell |
|
|||||
|
2021
Q4 | $1.96M | Buy |
|
|||||
|
2021
Q3 | $1.42M | Sell |
|
|||||
|
2021
Q2 | $4.01M | Buy |
|
|||||
|
2021
Q1 | $3.54M | Buy |
|
|||||
|
2020
Q4 | $272K | Buy |
|
|||||
|
2020
Q3 | $237K | Sell |
|
|||||
|
2020
Q2 | $2.58M | Buy |
|
|||||
|
2020
Q1 | $1.31M | Buy |
|
|||||
|
2019
Q4 | $526K | Sell |
|
|||||
|
2019
Q3 | $1.23M | Buy |
|
|||||
|
2019
Q2 | $157K | Buy |
|
|||||
|
2019
Q1 | $137K | Sell |
|
|||||
|
2018
Q4 | $1.23M | Buy |
|
|||||
|
2018
Q3 | $182K | Sell |
|
|||||
|
2018
Q2 | $882K | Buy |
|
|||||
|
2018
Q1 | $286K | Buy |
|
|||||
|
2017
Q4 | $34K | Buy |
|
|||||
|
2017
Q3 | $19K | Buy |
|
|||||
|
2017
Q2 | $1K | Sell |
|
|||||
|
2017
Q1 | $11K | Buy |
|
|||||
|
2016
Q4 | $6K | Hold |
|
|||||
|
2016
Q3 | $6K | Sell |
|
|||||
|
2016
Q2 | $24K | Sell |
|
|||||
|
2016
Q1 | $157K | Sell |
|
|||||
|
2015
Q4 | $256K | Buy |
|
|||||
|
2015
Q3 | $111K | Sell |
|
|||||
|
2015
Q2 | $395K | Sell |
|
|||||
|
2015
Q1 | $462K | Buy |
|
|||||
|
2014
Q4 | $343K | Buy |
|
|||||
|
2014
Q3 | $29K | Buy |
|
|||||
|
2014
Q2 | $5K | Sell |
|
|||||
|
2014
Q1 | $5K | Sell |
|
|||||
|
2013
Q4 | $88K | Buy |
|